We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
04 May 2021 - 07 May 2021
Virtual Venue

Hemoglobin Levels Measured with AI Microscope, Microfluidic Chips

By LabMedica International staff writers
Posted on 10 Mar 2021
Print article
Image: Workflow for hemoglobin estimation using an automated microscope (Photo courtesy of Sigtuple Technologies).
Image: Workflow for hemoglobin estimation using an automated microscope (Photo courtesy of Sigtuple Technologies).
A complete blood count can help ascertain the health of a patient and typically includes an estimate of the hemoglobin concentration, which can indicate several conditions, including anemia, polycythemia, and pulmonary fibrosis.

All techniques used in the estimation of hemoglobin in the blood can be classified into invasive and non-invasive. Non-invasive techniques, though very convenient because of the absence of needle prick, suffer from inferior performance; therefore, these techniques are almost always used as screening tools.

Bioengineers at Sigtuple Technologies (Bengaluru, India) and the Indian Institute of Science (Bengaluru, India) have developed a new AI-powered imaging-based tool to estimate hemoglobin levels. The setup was developed in conjunction with a microfluidic chip and an AI-powered automated microscope that was designed for deriving the total as well as differential counts of blood cells. The assay parameters, including SLS reagent-to-blood volume ratio, total reaction volume, the concentration of sodium dodecyl sulfate, and microfluidic chamber design, were optimized in order to achieve quantitation capability across a clinical range of hemoglobin using a path length suitable for the microfluidic platform.

Besides quantitative correlation with a clinically accepted-validated standard method, the spectral absorption characteristics of the hemoglobin–SLS reagent mixture in the newly developed assay were compared with those of conventional SLS assays. The SLS–blood/Hb standard solutions were analyzed using Erba Chem 5× clinical chemical analyzer (ERBA Diagnostics GmbH, Mannheim, Germany), and for hemoglobin estimation, the recommended settings with absorbance measurement at 546 nm were used. All UV–vis absorption measurements were performed using the NanoPhotometer NP 80, IMPLEN, Munich, Germany). The hemoglobin concentrations of both blood samples and in-house prepared hemoglobin standard solutions were measured using a commercial XP-100 hematology analyzer (Sysmex, Kobe, Japan).

The scientists reported that the microfluidic chip in combination with an automated microscope was able to achieve a Pearson correlation of 0.99 in a validation study comparing the newly developed method and a commercially available hematology analyzer, with a turnaround time of 10 minutes, including incubation time. The clinical performance was ascertained, and the method achieved a sensitivity of 92.3% and a specificity of 53.8%.

The automated microscope, which normally uses a combination of the red, green, and blue LED, used just the green LED during the hemoglobin estimation mode, and additionally, the grayscale values from the green channel of the image generated by an e-con camera. These optimized parameters, including exposure time, gain, white balance, and local tone mapping, were found to result in a setup capable of measuring hemoglobin in the blood, which was demonstrated through a clinical verification with 27 blood samples. Besides measuring hemoglobin in the blood, a similar setup with minor modifications could be used to measure protein content, cholesterol, and glycated hemoglobin. The study was published on February 23, 2021 in the journal AIP Advances.

Related Links:
Sigtuple Technologies
Indian Institute of Science
ERBA Diagnostics
IMPLEN
Sysmex


Gold Supplier
Clinical Chemistry Series
Clinical Chemistry Series
New
Gold Supplier
Tumor Marker Control
Tumor Marker Control
New
Gold Supplier
SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test
New
COVID-19 ELISA Test
Kantaro COVID-SeroKlir

Print article
BIOHIT  Healthcare OY

Channels

Molecular Diagnostics

view channel
Image: The EZ DNA Methylation-Direct Kit (Photo courtesy of Zymo Research)

Leukocyte Epigenomics and Artificial Intelligence Predict Late-Onset Alzheimer’s Disease

Alzheimer’s Disease (AD) is the most common form of age-related dementia, accounting for 60%–80% of such cases. The disorder causes a wide range of significant mental and physical disabilities, with profound... Read more

Industry

view channel
Image: The Novodiag platform combines real-time PCR and microarray capabilities to provide high-level multiplexing (Photo courtesy of Mobidiag Ltd.)

Hologic to Acquire Mobidiag to Strengthen Diagnostic Testing Business

Hologic, Inc. (Marlborough, MA, USA) has signed a definitive agreement to acquire Mobidiag Ltd. (Espoo, Finland) in a USD 795 million transaction that will accelerate the global growth of Mobidiag’s differentiated... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.